As of 2024-12-14, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (21.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -467.0%.
The range of the Relative Valuation is (19.93) - (18.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
Forward P/E multiples | 18.7x - 19.2x | 19.0x |
Fair Price | (19.93) - (18.49) | (21.55) |
Upside | -439.5% - -414.9% | -467.0% |
Date | P/E |